Centers for Disease Control and Prevention. (2023). Pneumococcal conjugate vaccine: What you need to know.
Centers for Disease Control and Prevention. (2023). Pneumococcal disease.
Centers for Disease Control and Prevention. (2023). Pneumococcal vaccination.
Centers for Disease Control and Prevention. (2023). Pneumococcal vaccination: Summary of who and when to vaccinate.
Centers for Disease Control and Prevention. (2023). Pneumococcal vaccination: What everyone should know.
Centers for Disease Control and Prevention. (2023). Prevention.
Centers for Disease Control and Prevention. (2023). Risk factors and how it spreads.
Centers for Disease Control and Prevention. (2024). ACIP recommendations.
Merck & Co., Inc. (2021). Merck announces U.S. FDA approval of Vaxneuvance™ (pneumococcal 15-valent conjugate vaccine) for the prevention of invasive pneumococcal disease in adults 18 years and older caused by 15 serotypes.
Merck Sharp & Dohme LLC. (2023). Vaxneuvance- pneumococcal 15-valent conjugate vaccine crm197 protein adsorbed injection, suspension [package insert]. DailyMed.
World Health Organization. (2020). How do vaccines work?


